Genome characterization of the SARS-CoV-2 omicron in Cameroon
BMC Infectious Diseases·
- DOI
- 10.1186/s12879-026-13029-8
- PMID
- 41840518
- PMCID
- PMC13104191
- OpenAlex
- W7136241280
- Study type
- Genomic study
- Publisher
- Springer Science and Business Media LLC
- Article type
- journal-article
- Integrity
- current
Why this research matters now
Persistent genomic surveillance remains essential for spotting novel strains and guiding immunization policy adjustments. The widespread presence of antibody-evasion mutations indicates potential pressures on existing preventive measures.
Structured evidence summary
Research question
The investigation seeks to outline the genetic profile of circulating Omicron subvariants in Cameroon and evaluate their possible effects on viral progression and antibody resistance.
Study design
This work employs a retrospective genomic approach utilizing publicly archived viral sequences.
Population and setting
The dataset comprises full-length Omicron genomes obtained from across Cameroon and deposited in an international sequencing repository.
Main findings
Among 1,428 examined genomes, eleven distinct lineages were identified, with BA.1 representing nearly half of the sample. Every variant carried spike gene alterations previously linked to reduced neutralizing antibody activity. The JN.1 strain exhibited the largest collection of genetic modifications.
Public-health relevance
Persistent genomic surveillance remains essential for spotting novel strains and guiding immunization policy adjustments. The widespread presence of antibody-evasion mutations indicates potential pressures on existing preventive measures.
Important limitations
The analysis depends entirely on retrospectively collected sequences shared through a public database, which may introduce sampling biases regarding local circulation patterns. Functional assays or clinical outcome correlations were not included in the evaluation.
GIDS interpretation
This report documents the regional genetic landscape of Omicron descendants, offering contextual data on mutation prevalence that could inform future tracking frameworks. It serves as a historical reference for variant diversity rather than a real-time alert mechanism.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 12 auditable classifier relationships to diseases, places, topics, and study design.